Matthew Henn

Chief Tech/Sci/R&D Officer at SERES THERAPEUTICS, INC.

Net worth: 47 133 $ as of 30/04/2024

49 year

Consumer Services

Health Technology

Matthew Henn active positions

Companies	Position	Start	End
SERES THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	07/02/2019	-
SERES THERAPEUTICS, INC.	Corporate Officer/Principal	01/06/2012	07/02/2019

Companies	Position	Start	End
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/03/2005	01/06/2012
Viral Genomics, Inc.	Director/Board Member	-	-

University of California, Berkeley	Doctorate Degree
University of New Hampshire	Undergraduate Degree

International

United States

Operational

Corporate Officer/Principal	2
Doctorate Degree	1
Chief Tech/Sci/R&D Officer	1

Sectoral

Consumer Services	3
Health Technology	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
SERES THERAPEUTICS, INC.	Health Technology

Private companies	2
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Health Technology
Viral Genomics, Inc.

Private companies

Health Technology

Viral Genomics, Inc.